Literature DB >> 20068260

Update of the drug resistance mutations in HIV-1: December 2009.

Victoria A Johnson1, Francoise Brun-Vezinet, Bonaventura Clotet, Huldrych F Gunthard, Daniel R Kuritzkes, Deenan Pillay, Jonathan M Schapiro, Douglas D Richman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 20068260

Source DB:  PubMed          Journal:  Top HIV Med        ISSN： 1542-8826


× No keyword cloud information.
  83 in total

1.  Lasso regularization for left-censored Gaussian outcome and high-dimensional predictors.

Authors:  Perrine Soret; Marta Avalos; Linda Wittkop; Daniel Commenges; Rodolphe Thiébaut
Journal:  BMC Med Res Methodol       Date:  2018-12-04       Impact factor: 4.615

2.  Viremia and drug resistance among HIV-1 patients on antiretroviral treatment: a cross-sectional study in Soweto, South Africa.

Authors:  Ziad El-Khatib; Anna Mia Ekstrom; Johanna Ledwaba; Lerato Mohapi; Fatima Laher; Alan Karstaedt; Salome Charalambous; Max Petzold; David Katzenstein; Lynn Morris
Journal:  AIDS       Date:  2010-07-17       Impact factor: 4.177

3.  HIV-1 drug resistance at antiretroviral treatment initiation in children previously exposed to single-dose nevirapine.

Authors:  Gillian M Hunt; Ashraf Coovadia; Elaine J Abrams; Gayle Sherman; Tammy Meyers; Lynn Morris; Louise Kuhn
Journal:  AIDS       Date:  2011-07-31       Impact factor: 4.177

Review 4.  Biochemistry and biophysics of HIV-1 gp41 - membrane interactions and implications for HIV-1 envelope protein mediated viral-cell fusion and fusion inhibitor design.

Authors:  Lifeng Cai; Miriam Gochin; Keliang Liu
Journal:  Curr Top Med Chem       Date:  2011-12       Impact factor: 3.295

5.  Mutual information analysis reveals coevolving residues in Tat that compensate for two distinct functions in HIV-1 gene expression.

Authors:  Siddharth S Dey; Yuhua Xue; Marcin P Joachimiak; Gregory D Friedland; John C Burnett; Qiang Zhou; Adam P Arkin; David V Schaffer
Journal:  J Biol Chem       Date:  2012-01-17       Impact factor: 5.157

6.  Genotyping external quality assurance in the World Health Organization HIV drug resistance laboratory network during 2007-2010.

Authors:  Neil Parkin; James Bremer; Silvia Bertagnolio
Journal:  Clin Infect Dis       Date:  2012-05       Impact factor: 9.079

7.  Prevalence, mutation patterns, and effects on protease inhibitor susceptibility of the L76V mutation in HIV-1 protease.

Authors:  Thomas P Young; Neil T Parkin; Eric Stawiski; Tami Pilot-Matias; Roger Trinh; Dale J Kempf; Michael Norton
Journal:  Antimicrob Agents Chemother       Date:  2010-08-30       Impact factor: 5.191

8.  Directly observed antiretroviral therapy in substance abusers receiving methadone maintenance therapy does not cause increased drug resistance.

Authors:  James C M Brust; Alain H Litwin; Karina M Berg; Xuan Li; Moonseong Heo; Julia H Arnsten
Journal:  AIDS Res Hum Retroviruses       Date:  2010-11-23       Impact factor: 2.205

9.  HIV-1 protease mutations and protease inhibitor cross-resistance.

Authors:  Soo-Yon Rhee; Jonathan Taylor; W Jeffrey Fessel; David Kaufman; William Towner; Paolo Troia; Peter Ruane; James Hellinger; Vivian Shirvani; Andrew Zolopa; Robert W Shafer
Journal:  Antimicrob Agents Chemother       Date:  2010-07-26       Impact factor: 5.191

10.  Differences in the interactions between the subunits of photosystem II dependent on D1 protein variants in the thermophilic cyanobacterium Thermosynechococcus elongatus.

Authors:  Miwa Sugiura; Eri Iwai; Hidenori Hayashi; Alain Boussac
Journal:  J Biol Chem       Date:  2010-07-14       Impact factor: 5.157
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.